香港六合彩中特网

A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson鈥檚 disease, a new 香港六合彩中特网-led study suggests, paving the way for further research to define its efficacy and safety.

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson鈥檚 Research (MJFF), found that people with Parkinson鈥檚 who injected themselves each week with exenatide for one year performed better in movement (motor) tests than those who injected a placebo.

鈥淭his is a very promising finding, as the drug holds potential to affect the course of the disease itself, and not merely the symptoms,鈥� said the study鈥檚 senior author, Professor Tom Foltynie (香港六合彩中特网 Institute of Neurology). 鈥淲ith existing treatments, we can relieve most of the symptoms for some years, but the disease continues to worsen.鈥�

See the 香港六合彩中特网 press release for the full story.